ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - Οφθαλμολογικά - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
metabolase, solution for injection for cattle, other large ruminants, horses, swine, sheep, goats, rabbits, dogs and cats.
qv03ax - granted - fatro spa italy - n. a. chance trading co
sebacil διάλυμα εξωτερικής χρήσης για χοίρους
qp53af01 - granted - bayer animal health gmbh - activet ltd